Vikas Mehta | Sep 12, 2024, 1:02 PM IST
The company said in a statement that the DCGI has approved the eye drop after a valid clinical trial was conducted on 234 patients which showed safety and efficacy of the eye drop. It said the patients of Presbyopia , who used the eye drop, were able to read lines on Snellen's Chart.
India.com News Desk | Feb 12, 2023, 10:34 PM IST
The notice stated that the DCGI had forwarded the order to all state and Union Territories in May and November 2019 and again on February 3 for necessary action and compliance.
India.com News Desk | Sep 6, 2022, 3:14 PM IST
The nasal Covid vaccine had last month completed the phase-III and booster dose trials and Bharat Biotech said it had conducted two separate trials for its intranasal Covid vaccine, one as a primary dose schedule and another as a booster dose.
India.com News Desk | Jul 12, 2022, 10:13 PM IST
The DCGI on Tuesday granted market authorisation to Serum Institute to produce India's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer.
India.com News Desk | Jun 24, 2022, 11:14 PM IST
Drugs Controller General of India (DCGI) had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years age group subject to certain conditions on March 9.
India.com News Desk | Jun 15, 2022, 10:52 PM IST
Cervical cancer in India ranks as the second most frequent cancer among women between 15 and 44 years of age.
PTI | Feb 7, 2022, 8:46 PM IST
Director, Government and Regulatory Affairs at the SII, Prakash Kumar Singh had put in an application to the DCGI on January 6
India.com News Desk | Feb 6, 2022, 8:52 PM IST
This is the 9th COVID-19 vaccine in the country, Union Health Minister Mansukh Mandaviya tweeted.
India.com News Desk | Feb 4, 2022, 11:12 PM IST
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval.
India.com News Desk | Jan 27, 2022, 3:18 PM IST
Drugs Controller General of India (DCGI) grants conditional market approval for Covishield and Covaxin.
India.com News Desk | Oct 12, 2021, 1:25 PM IST
Two doses of Covaxin are likely to be administered to children with a gap of 28 days. For adults, the government has set a gap of 4-6 weeks between the two shots.
India.com News Desk | Sep 15, 2021, 10:13 AM IST
Testing for Sputnik Light's phase-3 trials will now begin in India soon as the first tranche has been sent for quality and safety validation.
English
